The criteria for choosing drugs to use in maintenance therapy of asthma are related to the identification of the classes of drugs most active in attaining a better quality of life for the asthmatic patient. A rational programme must reduce the number of hospital admissions, reduce the number and frequency of asthmatic attacks, improve airway patency, improve the patient's capacity to cope with the daily situations in which they may find themselves in difficulty because of their bronchial hyperreactivity, and must use the pharmacological resources in such a way as to establish the best possible balance between the attainment of therapeutic benefits and occurrence of side-effects.
|Number of pages||3|
|Journal||European Respiratory Review|
|Publication status||Published - 1993|
ASJC Scopus subject areas
- Pulmonary and Respiratory Medicine